Doha: The world marks World Diabetes Day on November 14 each year, aiming to raise global awareness to combat the disease and its complications, as well as to focus on prevention and management strategies after diagnosis. This year, the emphasis is on urging public and private sectors to provide a safe working environment for diabetic patients as part of the global "Diabetes in the Workplace" initiative.
According to Qatar News Agency, the International Diabetes Federation and the World Health Organization (WHO) report that the number of adults living with diabetes worldwide has surpassed 800 million, more than quadrupling since 1990. Most affected individuals are between the ages of 20 and 79. Alarmingly, about 43% of people with diabetes are unaware of their condition, placing them at risk of serious complications. Moreover, it is projected that nearly 81% of individuals with diabetes reside in low- and middle-income countries.
Statistics indicate that in 2024, global diabetes-related health expenditure surpassed USD 1 trillion. The economic impact is particularly severe in low- and middle-income countries, where the burden of untreated cases is higher, straining health systems and economies. Specialists attribute the rise in diabetes cases to lifestyle changes, including weight gain, lack of physical activity, and dietary habits, underscoring the need for comprehensive societal awareness and scientific understanding.
Dr. Abdullah Al Hamaq, Executive Director of Qatar Diabetes Association (QDA), highlighted the organization's efforts in supporting diabetic patients. The QDA organizes over 50 awareness activities annually, such as workshops, seminars, and screening campaigns. Dr. Al Hamaq noted that the association provides direct support to over 3,000 patients yearly through educational programs and psychological and nutritional guidance. National campaigns aim to raise community awareness, and collaborations with schools and workplaces promote prevention and healthy management.
Dr. Al Hamaq emphasized the improvement in diabetes awareness and knowledge in Qatar, particularly among young people, although challenges remain in treatment adherence and lifestyle maintenance. Globally, while awareness is increasing, complications like heart and kidney diseases persist due to inadequate follow-up or delayed diagnosis.
He also mentioned recent scientific advances in diabetes prevention and management, including continuous glucose monitoring devices and new medications like SGLT2 and GLP-1 inhibitors, which enhance blood sugar control and reduce complications.